- Report
- August 2025
- 150 Pages
Global
From €2951EUR$3,358USD£2,553GBP
€3472EUR$3,950USD£3,003GBP
- Report
- August 2025
- 150 Pages
Global
From €2951EUR$3,358USD£2,553GBP
€3472EUR$3,950USD£3,003GBP
- Report
- August 2025
- 150 Pages
Global
From €2951EUR$3,358USD£2,553GBP
€3472EUR$3,950USD£3,003GBP
- Report
- July 2025
- 350 Pages
Global
From €4350EUR$4,949USD£3,763GBP
- Report
- July 2025
- 350 Pages
Global
From €4350EUR$4,949USD£3,763GBP
- Report
- August 2025
- 145 Pages
Global
From €2778EUR$3,160USD£2,403GBP
€3472EUR$3,950USD£3,003GBP
- Report
- May 2025
- 52 Pages
Global
From €6592EUR$7,500USD£5,702GBP
- Report
- December 2024
- 438 Pages
Global
From €3516EUR$4,000USD£3,041GBP
- Report
- July 2025
- 94 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- March 2025
- 110 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- January 2025
- 99 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- January 2025
- 89 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- March 2025
- 96 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- August 2025
- 150 Pages
Global
From €2876EUR$3,273USD£2,488GBP
€3384EUR$3,850USD£2,927GBP
- Report
- August 2025
- 144 Pages
Global
From €3101EUR$3,528USD£2,682GBP
€3648EUR$4,150USD£3,155GBP
- Report
- April 2025
- 88 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- September 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,927GBP
- Report
- July 2025
- 150 Pages
Global
From €3384EUR$3,850USD£2,927GBP
€4263EUR$4,850USD£3,687GBP
- Report
- July 2025
- 155 Pages
Global
From €3624EUR$4,123USD£3,134GBP
€4263EUR$4,850USD£3,687GBP
- Report
- July 2025
- 170 Pages
Global
From €3624EUR$4,123USD£3,134GBP
€4263EUR$4,850USD£3,687GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more